Bioptic Inc. (6850) Stock Statistics & Valuation Metrics
Total Valuation
Bioptic Inc. has a market cap or net worth of TWD 936.41M. The enterprise value is ―.
- Market Cap
- TWD 936.41M
- Enterprise Value
- ―
Share Statistics
Bioptic Inc. has 33,088,660 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 33,088,660
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Bioptic Inc.’s return on equity (ROE) is 0.00 and return on invested capital (ROIC) is -1.29%.
- Return on Equity (ROE)
- 0.00
- Return on Assets (ROA)
- 0.00
- Return on Invested Capital (ROIC)
- -1.29%
- Return on Capital Employed (ROCE)
- 0.07
- Revenue Per Employee
- 2.95M
- Profits Per Employee
- 15.25K
- Employee Count
- 80
- Asset Turnover
- 0.41
- Inventory Turnover
- 0.80
Valuation Ratios
The current PE Ratio of Bioptic Inc. is 110.00. Bioptic Inc.’s PEG ratio is -1.69.
- PE Ratio
- 110.00
- PS Ratio
- 3.92
- PB Ratio
- 2.34
- Price to FCF
- 11.90
- Price to Operating Cash Flow
- 12.96
- PEG Ratio
- -1.69
Income Statement
In the last 12 months, Bioptic Inc. had revenue of 236.13M and earned 1.22M in profits. Earnings per share was 0.04.
- Revenue
- 236.13M
- Gross Profit
- 141.66M
- Operating Income
- 39.09M
- Pretax Income
- 5.91M
- Net Income
- 1.22M
- EBITDA
- 56.20M
- Earnings Per Share (EPS)
- 0.04
Cash Flow
In the last 12 months, operating cash flow was 79.06M and capital expenditures -2.58M, giving a free cash flow of 76.48M billion.
- Operating Cash Flow
- 79.06M
- Free Cash Flow
- 76.48M
- Free Cash Flow per Share
- 2.05
Dividends & Yields
Bioptic Inc. pays an annual dividend of ―, resulting in a dividend yield of 1.77%
- Dividend Per Share
- ―
- Dividend Yield
- 1.77%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 8.41%
- Earnings Yield
- 0.83%
Stock Price Statistics
- Beta
- 0.17
- 52-Week Price Change
- -32.62%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- 30.78
- Average Volume (3m)
- 16.57K
Financial Position
Bioptic Inc. as a current ratio of 7.26, with Debt / Equity ratio of 19.40%
- Current Ratio
- 7.26
- Quick Ratio
- 4.54
- Debt to Market Cap
- 0.07
- Net Debt to EBITDA
- -1.50
- Interest Coverage Ratio
- 19.68
Taxes
In the past 12 months, Bioptic Inc. has paid 6.97M in taxes.
- Income Tax
- 6.97M
- Effective Tax Rate
- 1.18
Enterprise Valuation
Bioptic Inc. EV to EBITDA ratio is 12.99, with an EV/FCF ratio of 10.49.
- EV to Sales
- 3.46
- EV to EBITDA
- 12.99
- EV to Free Cash Flow
- 10.49
- EV to Operating Cash Flow
- 10.15
Balance Sheet
Bioptic Inc. has TWD 188.24M in cash and marketable securities with TWD 80.56M in debt, giving a net cash position of TWD 107.68M billion.
- Cash & Marketable Securities
- TWD 188.24M
- Total Debt
- TWD 80.56M
- Net Cash
- TWD 107.68M
- Net Cash Per Share
- TWD 3.25
- Tangible Book Value Per Share
- TWD 11.79
Margins
Gross margin is 59.94%, with operating margin of 13.97%, and net profit margin of 3.65%.
- Gross Margin
- 59.94%
- Operating Margin
- 13.97%
- Pretax Margin
- 7.66%
- Net Profit Margin
- 3.65%
- EBITDA Margin
- 26.63%
- EBIT Margin
- 13.97%
Analyst Forecast
The average price target for Bioptic Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -0.19%
- EPS Growth Forecast
- -61.67%
